Remus Pharmaceuticals shareholding pattern
92514.85 (1.63%)
Last updated on 28 Aug, 2026 | 15:24 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Remus Pharmaceuticals Shareholding Pattern
- 2024-25
- 2026-27
- 2025-26
- 2023-24
Total Promoters
Segment
Percent
Total Promoters
70.84%
Mutual Fund
0%
Insurance
0%
Foreign Institutional Investors
3.16%
Domestic Institutional Investors
0.77%
Retail
25.22%
Others
0.01%
Total Promoters
MAR '24
70.6%
SEP '24
70.84%
Summary
Remus Pharmaceuticals share holding pattern reports the following shareholding: Remus Pharmaceuticals Total Promoters is at 70.95%, Mutual Fund at 0.00%, Insurance at 0.00%, Foreign Institutional Investors at 5.28%, Domestic Institutional Investors at 0.83%, and Retail at 22.94%. This breakdown provides a quick snapshot of ownership distribution for Remus Pharmaceuticals share holding pattern in 2026-27.
Remus Pharmaceuticals Associated Pages
- Remus Pharmaceuticals
Share Price - Remus Pharmaceuticals
Share Price chart - Remus Pharmaceuticals
Fundamental Analysis - Remus Pharmaceuticals
Technical Analysis - Remus Pharmaceuticals
Peer Comparison - Remus Pharmaceuticals
Share Price History - Remus Pharmaceuticals
Dividend - Remus Pharmaceuticals
Bonus Share - Remus Pharmaceuticals
Board of Directors
Remus Pharmaceuticals FAQs
As of 08-2026, the promoter shareholding in Remus Pharmaceuticals stands at 70.95% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Remus Pharmaceuticals is 5.28% and 0.83% respectively.
The retail shareholding of the Remus Pharmaceuticals is 22.94%.
Changes in shareholding patterns of Remus Pharmaceuticals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Remus Pharmaceuticals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in REMUS
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC